CTSH
51
6
SWKS
66
7
EXR
57
-2
HD
55
-2
FOXA
38
4
HBAN
33
2
GILD
38
12
TAP
37
2
ABBV
70
2
URBN
67
-3
IPG
45
-2
JNJ
30
6
MTB
57
8
STX
59
-5
D
37
5
TMO
54
-2
EXC
47
7
QCOM
78
-6
STI
3
2
DNB
32
4
CTSH
51
6
SWKS
66
7
EXR
57
-2
HD
55
-2
FOXA
38
4
HBAN
33
2
GILD
38
12
TAP
37
2
ABBV
70
2
URBN
67
-3
IPG
45
-2
JNJ
30
6
MTB
57
8
STX
59
-5
D
37
5
TMO
54
-2
EXC
47
7
QCOM
78
-6
STI
3
2
DNB
32
4
Financhill
Back

Julius Baer Gruppe AG Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
37

JBAXY
Julius Baer Gruppe AG

Last Price:
11.30
Seasonality Move:
2.59%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
37
Julius Baer Gruppe AG (JBAXY) is a Sell

Is Julius Baer Gruppe AG a Buy, Sell or Hold?

  • The current Julius Baer Gruppe AG [JBAXY] share price is $11.52. The Score for JBAXY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • JBAXY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JBAXY Stock Price Chart

What is Julius Baer Gruppe AG's stock price today?

  • The Julius Baer Gruppe AG share price today is $11.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JBAXY is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

JBAXY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 47.68 Sell
Chaikin Money Flow: 57401 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.51 - 12.05) Sell
Bollinger Bands (100): (10.75 - 11.75) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

JBAXY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.49 Buy
20-day SMA: 11.73 Sell
50-day SMA: 11.42 Buy
200-day SMA: 11.47 Buy
8-day EMA: 11.56 Sell
20-day EMA: 11.62 Sell
50-day EMA: 11.53 Sell
200-day EMA: 11.56 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

Julius Baer Gruppe AG Earnings Growth & JBAXY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Julius Baer Gruppe AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):